+36.1%
MRNA vs AEHR
+88.1%
-52.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AEHR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.9% | +4.4% | +5.3% |
| 7D | -1.1% | +9.8% | -10.9% | -1.9% |
| 30D | +126.1% | -26.7% | +152.8% | +130.0% |
| 3M | +190.0% | -8.1% | +198.1% | +177.3% |
| 6M | +157.2% | +123.1% | +34.2% | +105.8% |
| YTD | +388.2% | +369.0% | +19.2% | +237.2% |
| 1Y | +467.0% | +256.4% | +210.7% | +302.5% |
| 3Y | +36.1% | +96.4% | -60.3% | -14.5% |
| All | +36.1% | +88.1% | -52.0% | -14.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AEHR.
Daily Out/Under-Performance
Portfolio return minus AEHR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AEHR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AEHR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling